Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,317 | 25,878 | 45,744 | 66,943 | N/A |
| Receivables | 264 | 207 | 369 | 325 | N/A |
| TOTAL | $23,111 | $26,782 | $47,258 | $69,529 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 143 | 250 | 228 | 284 | N/A |
| Intangibles | 0 | 156 | 227 | 303 | 0 |
| TOTAL | $143 | $406 | $454 | $587 | $N/A |
| Total Assets | $23,254 | $27,188 | $47,712 | $70,116 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,092 | 5,957 | 7,180 | 3,877 | 0 |
| Other current liabilities | N/A | 176 | 323 | 5,315 | N/A |
| TOTAL | $5,116 | $6,145 | $7,542 | $9,228 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $92 | $117 | $17 | $58 | $N/A |
| Total Liabilities | $5,207 | $6,263 | $7,559 | $9,286 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 61,923 | N/A |
| Common Shares | 130,879 | 110,023 | 113,492 | 114,035 | N/A |
| Retained earnings | -130,820 | -105,621 | -88,034 | -66,639 | N/A |
| Other shareholders' equity | 0 | 2,606 | 2,706 | 3,333 | 0 |
| TOTAL | $18,047 | $20,925 | $40,154 | $60,830 | $N/A |
| Total Liabilities And Equity | $23,254 | $27,188 | $47,712 | $70,116 | $0 |